कंपनी का अवलोकन
ZeroStack Corp. operates primarily through its subsidiary, Phatebo GmbH, engaging in pharmaceutical distribution within the German market while also managing digital assets. The entity functions within the broader Financial Services sector, specifically classified under the Asset Management industry, indicating a focus on managing capital or financial resources rather than traditional banking or insurance operations. The company's current scale is characterized by a market capitalization of $11.98M, an annual revenue of $35.68M, and an employee base of 21 individuals. These financial figures suggest a small-cap enterprise with a significant revenue figure relative to its size, which often implies high operating leverage or a niche market position where a small workforce generates substantial turnover. However, the disparity between the $11.98M market cap and the $35.68M revenue indicates that the market values the company at less than half its sales figure, reflecting a lack of confidence in future earnings potential or significant concerns regarding profitability and debt obligations. The low employee count of 21 further underscores the capital-intensive nature of its business model, likely driven by inventory management costs in the pharmaceutical sector rather than labor expenses.
वित्तीय स्वास्थ्य
The company reported a revenue of $35.68M over the trailing twelve months, yet it recorded a net income of -$115,410,000 and an EBITDA of -$11,027,000. The substantial gap between the positive revenue of $35.68M and the deeply negative net income of -$115.41M reveals a cost structure where expenses, particularly interest or depreciation, are far exceeding operating profits, resulting in a loss that is significantly larger than the underlying operating deficit. Free cash flow stands at -$5,176,000, indicating that the company is burning cash operations rather than generating liquidity, which severely limits its financial flexibility for expansion or dividend payments without external financing. Margin analysis shows a Gross Margin of 4.6%, an Operating Margin of -54.8%, and a Profit Margin of 0.0%, illustrating that while the core product sales retain some value, operational inefficiencies and high fixed costs erade profitability to the point where the company breaks even on a profit basis only in name while losing money on operations. On the balance sheet, cash holdings of $5.60M are vastly outweighed by total debt of $53.93M, creating a precarious liquidity position. This leverage is quantified by a Debt to Equity ratio of 76.44, signaling a highly leveraged balance sheet where debt obligations are substantial relative to shareholders' equity. Short-term liquidity is constrained further by a Current Ratio of 1.01, meaning current assets barely cover current liabilities, leaving little room for unexpected cash outflows. Furthermore, the Return on Equity of -307.5% and Return on Assets of -9.3% demonstrate that management is effectively destroying shareholder value and failing to utilize assets to generate positive returns.
मूल्यांकन आकलन
Trailing P/E and forward P/E ratios are both N/A due to the company's consistent losses, implying that traditional earnings-based valuation multiples are currently inapplicable and that investors are pricing the stock based on asset value or revenue multiples instead. The Price to Book ratio is 0.07, indicating that the stock trades at a deep discount to its book value, which often suggests the market perceives significant hidden liabilities or doubts about the recoverability of the company's assets given the high debt load. Alternative valuation metrics such as Price to Sales of 0.34 and an EV/EBITDA of -5.47 suggest that the market is pricing the company at a fraction of its sales, reflecting extreme pessimism regarding future earnings normalization. The stock's price range over the past year spans from a 52-Week Low of $4.78 to a 52-Week High of $47.00, highlighting extreme volatility in investor sentiment. Without a specific current price provided in the facts to calculate the exact percentage relative to the high or low, the metrics show a range where the stock has experienced massive swings, trading anywhere between 90% below the high and near the low depending on market conditions. The Beta of 2.01 indicates that the stock's price volatility is twice that of the broader market, making it an extremely risky speculative vehicle that will amplify market movements in both directions. The negative EV/EBITDA of -5.47 reinforces that the company is currently unprofitable on an enterprise value basis, which complicates comparisons with profitable peers in the Asset Management sector.
Growth & Income
Revenue growth stands at 22.3% year-over-year, while earnings growth is N/A due to the persistent losses, implying that the top-line expansion is not yet translating into bottom-line profitability. Since the company is not a dividend payer, the dividend yield is N/A and the payout ratio is 0.0%, meaning the company reinvests its limited cash flows or existing reserves into operations rather than distributing income to shareholders. The lack of a dividend payout ratio confirms that all available resources are directed toward maintaining operations and servicing the $53.93M debt load rather than returning capital to investors. Overall, the growth and income profile presents a mixed picture of strong top-line expansion of 22.3% coupled with severe profitability challenges and no current income generation for investors seeking yield. The company's ability to sustain its 22.3% revenue growth while reducing its massive operating losses of -$115.41M and negative free cash flow of -$5.176M will be the primary determinant of its long-term valuation recovery.